Due to the COVID-19 pandemic, the global Recombinant Human Serum Albumin market size was US$ 74.84 million in 2022 and is forecast to a readjusted size of US$ 121.07 million by 2029 with a CAGR of 7.16% during the forecast period 2023-2029.
The North America Recombinant Human Serum Albumin market size was US$ 43.08 million in 2022, while China was US$ 2.16 million. The proportion of the North America was 57.56% in 2022, while Chinese percentage was 2.89%, and it is predicted that China share will reach 3.5% in 2029, trailing a CAGR of 9.87 % through the analysis period.
The global key manufacturers of Recombinant Human Serum Albumin include: Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia, and etc. In 2022, the global top five players occupied for a share approximately 90.81% in terms of revenue.
Scope and Market Size:
The global Recombinant Human Serum Albumin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Serum Albumin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.
By Company
- Albumedix
- Merck
- Ventria (InVitria)
- NCPC
- Oryzogen
- HiMedia
Segment by Type
Segment by Application
- Cell Culture Media
- Medical Supplements
- Other
By Region
- North America
- Europe
- Russia
- China
- Japan
- Southeast Asia
- India
- Other Regions
Table of Contents
1 Recombinant Human Serum Albumin Market Overview
- 1.1 Recombinant Human Serum Albumin Product Scope
- 1.2 Recombinant Human Serum Albumin by Type
- 1.2.1 Global Recombinant Human Serum Albumin Sales by Type (2018 & 2022 & 2029)
- 1.2.2 OsrHSA
- 1.2.3 ScrHSA
- 1.3 Recombinant Human Serum Albumin by Application
- 1.3.1 Global Recombinant Human Serum Albumin Sales Comparison by Application (2018 & 2022 & 2029)
- 1.3.2 Cell Culture Media
- 1.3.3 Medical Supplements
- 1.4 Global Recombinant Human Serum Albumin Market Estimates and Forecasts (2018-2029)
- 1.4.1 Global Recombinant Human Serum Albumin Market Size in Value Growth Rate (2018-2029)
- 1.4.2 Global Recombinant Human Serum Albumin Market Size in Volume Growth Rate (2018-2029)
- 1.4.3 Global Recombinant Human Serum Albumin Price Trends (2018-2029)
- 1.5 Assumptions and Limitations
2 Recombinant Human Serum Albumin Estimates and Forecasts by Region
- 2.1 Global Recombinant Human Serum Albumin Market Size by Region: 2018 VS 2022 VS 2029
- 2.2 Global Recombinant Human Serum Albumin Retrospective Market Scenario by Region (2018-2023)
- 2.2.1 Global Recombinant Human Serum Albumin Sales Market Share by Region (2018-2023)
- 2.2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Region (2018-2023)
- 2.3 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Region (2024-2029)
- 2.3.1 Global Recombinant Human Serum Albumin Sales Estimates and Forecasts by Region (2024-2029)
- 2.3.2 Global Recombinant Human Serum Albumin Revenue Forecast by Region (2024-2029)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
- 2.4.2 Europe Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
- 2.4.3 China Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
- 2.4.4 Japan Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
- 2.4.5 Southeast Asia Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
- 2.4.6 India Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
- 2.4.7 Russia Recombinant Human Serum Albumin Estimates and Projections (2018-2029)
3 Recombinant Human Serum Albumin Competition Landscape by Players
- 3.1 Global Recombinant Human Serum Albumin Sales by Players (2018-2023)
- 3.2 Global Top Recombinant Human Serum Albumin Players by Revenue (2018-2023)
- 3.3 Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin as of 2022)
- 3.4 Global Recombinant Human Serum Albumin Average Price by Company (2018-2023)
- 3.5 Global Key Manufacturers of Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters
- 3.6 Global Key Manufacturers of Recombinant Human Serum Albumin, Product Type
- 3.7 Global Key Manufacturers of Recombinant Human Serum Albumin, Founded Date
- 3.8 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Recombinant Human Serum Albumin Market Size by Type
- 4.1 Global Recombinant Human Serum Albumin Historic Market Review by Type (2018-2023)
- 4.1.1 Global Recombinant Human Serum Albumin Sales by Type (2018-2023)
- 4.1.2 Global Recombinant Human Serum Albumin Revenue by Type (2018-2023)
- 4.1.3 Global Recombinant Human Serum Albumin Price by Type (2018-2023)
- 4.2 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Type (2024-2029)
- 4.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Type (2024-2029)
- 4.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Type (2024-2029)
- 4.2.3 Global Recombinant Human Serum Albumin Price Forecast by Type (2024-2029)
5 Global Recombinant Human Serum Albumin Market Size by Application
- 5.1 Global Recombinant Human Serum Albumin Historic Market Review by Application (2018-2023)
- 5.1.1 Global Recombinant Human Serum Albumin Sales by Application (2018-2023)
- 5.1.2 Global Recombinant Human Serum Albumin Revenue by Application (2018-2023)
- 5.1.3 Global Recombinant Human Serum Albumin Price by Application (2018-2023)
- 5.2 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Application (2024-2029)
- 5.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Application (2024-2029)
- 5.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Application (2024-2029)
- 5.2.3 Global Recombinant Human Serum Albumin Price Forecast by Application (2024-2029)
6 North America Recombinant Human Serum Albumin Market Facts & Figures
- 6.1 North America Recombinant Human Serum Albumin Sales by Company
- 6.1.1 North America Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 6.1.2 North America Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 6.2 North America Recombinant Human Serum Albumin Sales Breakdown by Type
- 6.2.1 North America Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 6.2.2 North America Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 6.3 North America Recombinant Human Serum Albumin Sales Breakdown by Application
- 6.3.1 North America Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 6.3.2 North America Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
7 Europe Recombinant Human Serum Albumin Market Facts & Figures
- 7.1 Europe Recombinant Human Serum Albumin Sales by Company
- 7.1.1 Europe Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 7.1.2 Europe Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 7.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Type
- 7.2.1 Europe Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 7.2.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 7.3 Europe Recombinant Human Serum Albumin Sales Breakdown by Application
- 7.3.1 Europe Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 7.3.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
8 Russia Recombinant Human Serum Albumin Market Facts & Figures
- 8.1 Russia Recombinant Human Serum Albumin Sales by Company
- 8.1.1 Russia Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 8.1.2 Russia Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 8.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Type
- 8.2.1 Russia Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 8.2.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 8.3 Russia Recombinant Human Serum Albumin Sales Breakdown by Application
- 8.3.1 Russia Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 8.3.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
9 China Recombinant Human Serum Albumin Market Facts & Figures
- 9.1 China Recombinant Human Serum Albumin Sales by Company
- 9.1.1 China Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 9.1.2 China Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 9.2 China Recombinant Human Serum Albumin Sales Breakdown by Type
- 9.2.1 China Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 9.2.2 China Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 9.3 China Recombinant Human Serum Albumin Sales Breakdown by Application
- 9.3.1 China Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 9.3.2 China Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
10 Japan Recombinant Human Serum Albumin Market Facts & Figures
- 10.1 Japan Recombinant Human Serum Albumin Sales by Company
- 10.1.1 Japan Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 10.1.2 Japan Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 10.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Type
- 10.2.1 Japan Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 10.2.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 10.3 Japan Recombinant Human Serum Albumin Sales Breakdown by Application
- 10.3.1 Japan Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 10.3.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
11 India Recombinant Human Serum Albumin Market Facts & Figures
- 11.1 India Recombinant Human Serum Albumin Sales by Company
- 11.1.1 India Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 11.1.2 India Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 11.2 India Recombinant Human Serum Albumin Sales Breakdown by Type
- 11.2.1 India Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 11.2.2 India Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 11.3 India Recombinant Human Serum Albumin Sales Breakdown by Application
- 11.3.1 India Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 11.3.2 India Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
12 Southeast Asia Recombinant Human Serum Albumin Market Facts & Figures
- 12.1 Southeast Asia Recombinant Human Serum Albumin Sales by Company
- 12.1.1 Southeast Asia Recombinant Human Serum Albumin Sales by Company (2019-2023)
- 12.1.2 Southeast Asia Recombinant Human Serum Albumin Revenue by Company (2019-2023)
- 12.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type
- 12.2.1 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023)
- 12.2.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029)
- 12.3 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application
- 12.3.1 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023)
- 12.3.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029)
13 Company Profiles and Key Figures
- 13.1 Albumedix
- 13.1.1 Albumedix Corporation Information
- 13.1.2 Albumedix Recombinant Human Serum Albumin Products Offered
- 13.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 13.1.4 Albumedix Recent Developments
- 13.2 Merck
- 13.2.1 Merck Corporation Information
- 13.2.2 Merck Recombinant Human Serum Albumin Products Offered
- 13.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 13.2.4 Merck Recent Developments
- 13.3 Ventria (InVitria)
- 13.3.1 Ventria (InVitria) Corporation Information
- 13.3.2 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered
- 13.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 13.3.4 Ventria (InVitria) Recent Developments
- 13.4 NCPC
- 13.4.1 NCPC Corporation Information
- 13.4.2 NCPC Recombinant Human Serum Albumin Products Offered
- 13.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 13.5 Oryzogen
- 13.5.1 Oryzogen Corporation Information
- 13.5.2 Oryzogen Recombinant Human Serum Albumin Products Offered
- 13.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
- 13.6 HiMedia
- 13.6.1 HiMedia Corporation Information
- 13.6.2 HiMedia Recombinant Human Serum Albumin Products Offered
- 13.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023)
14 Recombinant Human Serum Albumin Manufacturing Cost Analysis
- 14.1 Recombinant Human Serum Albumin Key Raw Materials Analysis
- 14.1.1 Key Raw Materials
- 14.1.2 Key Suppliers of Raw Materials
- 14.2 Proportion of Manufacturing Cost Structure
- 14.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin
- 14.4 Recombinant Human Serum Albumin Industrial Chain Analysis
15 Marketing Channel, Distributors and Customers
- 15.1 Marketing Channel
- 15.2 Recombinant Human Serum Albumin Distributors List
- 15.3 Recombinant Human Serum Albumin Customers
16 Recombinant Human Serum Albumin Market Dynamics
- 16.1 Recombinant Human Serum Albumin Industry Trends
- 16.2 Recombinant Human Serum Albumin Market Drivers
- 16.3 Recombinant Human Serum Albumin Market Challenges
- 16.4 Recombinant Human Serum Albumin Market Restraints
17 Research Findings and Conclusion
18 Appendix
- 18.1 Research Methodology
- 18.1.1 Methodology/Research Approach
- 18.1.2 Data Source
- 18.2 Author Details
- 18.3 Disclaimer